Financial Disclosure

Actualizado Reviewed

 

Financial Disclosure List for Members of the U.S. Health and Human Services Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission (Reporting Period: December 2022 to December 2023)
NamePanel StatusCompanyRelationship
Abrams, Elaine J.MNoneN/A
Badell, Martina L. MNoneN/A
Best, Brookie M.MPPDDSMB
IQVIADSMB
Syneos HealthDSMB
EasthornDSMB
Boucoiran, IsabelleExOMModerna, Altona, FerringResearch Support
Brooks Kristina M.MViiVConsultant
Campbell, Danielle MNoneN/A
Chakhtoura, NahidaESNoneN/A
Chakraborty, RanaMNoneN/A
Chevalier, MichelleHHSNoneN/A
Ciaranello, AndreaCCNoneN/A
Cohn, Susan E.MViiV HealthcareScientific Adivosry Board
Cu-Uvin, Susan MAIDS Malignancy ConsortiumDSMB
Jao, JenniferMNoneN/A
Kakkar, FatimaExOMNoneN/A
Keeshin, Susana MNoneN/A
Kourtis, Athena, P.HHSNoneN/A
Lampe, Margaret

HHS

NoneN/A
Lazenby, Gweneth B.MNoneN/A
Levison, JudyMNoneN/A
Matthews, LynnMGileadResearch Support
Mirochnick, MarkCCViiVResearch Support
AstraZenecaDSMB
MerckResearch Support
GileadResearch Support
Mofenson, Lynne M.MViiV HealthcareResearch Support
Momplaisir, FloranceMNoneN/A
Mullick, Charu

HHS

NoneN/A
O’Connor HeatherMNoneN/A
Pollock, LealahExOMNoneN/A
Powell, AnnaMUpToDateAuthor
Prioleau, Fatima Y.MNoneN/A
Rahangdale, LisaMNoneN/A
Rosebush JuliaMNoneN/A
Scott, Rachel K.MViiVResearch Support
GSKResearch Support
GileadResearch Support
Sheffield, JeanneMNoneN/A
Sheth AnandiMNoneN/A
Short, William R.MViiVConsultant
Janssen Consultant
Siberry, George K.MNoneN/A
Sissoho, FatoumattaMNoneN/A
Spector, Stephen A.MJ&JStockholder
Storm, DeborahCMerckStockholder
Eli Lilly and CompanyStockholder
RocheStockholder
Viswanathan, PrabhaHHSNoneN/A
Wilcox, RonaldHHSNoneN/A
Wright, Rodney L.MNoneN/A
Yee, Lynn M.MNoneN/A
Zash, RebeccaMNoneN/A
Key: DSMB = Data Safety Monitoring Board; C=Consultant; CC = Panel Co-Chairs; ES = Executive Secretary; ExOM = Ex Officio Member; HHS = Member from Department of Health and Human Services; M = Member; N/A = Not applicable

 

Download Guidelines